Today: 17 June 2026

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Nokia (NOK) Stock Soars on $1B Nvidia Deal & Massive 5G Contract Wins

Nokia (NOK) Stock Soars on $1B Nvidia Deal & Massive 5G Contract Wins

Nokia shares surged 20–25% in late October 2025, reaching multi-year highs after strong Q3 results and news of a $1 billion investment from NVIDIA for a 2.9% stake. The companies announced a strategic AI and 6G networking partnership. Nokia’s Q3 sales rose 12% to €4.83 billion, beating forecasts, with operating profit at €435 million. Major 5G and network contracts were secured with Vodafone, Rakuten, Elisa, and E.ON.
30 October 2025
··
Ford (F) Stock Surges on Earnings – Rally Faces EV & Recall Challenges

Ford (F) Stock Surges on Earnings – Rally Faces EV & Recall Challenges

Ford shares jumped 10% after Q3 earnings beat forecasts, closing near a one-year high at around $13. Revenue hit $50.5 billion, up 9% year-over-year, but the company cut 2025 profit guidance by up to $2 billion due to a supplier fire. Ford’s EV unit continues to post losses, and the automaker faces record recalls and higher labor costs. The dividend resumed at $0.15 per share, with most analysts rating the stock a “Hold.”
30 October 2025
···
Explosive Rally and Volatility: Bitcoin’s Surge Propels Bitfarms Stock

Explosive Rally and Volatility: Bitcoin’s Surge Propels Bitfarms Stock

Bitfarms Ltd. (NASDAQ: BITF) stock surged from about $1 in January to over $6 in mid-October 2025, before dropping nearly 40% and rebounding to around $4.90 by Oct. 27. The company raised $588 million in convertible notes to fund a new Pennsylvania data center and expand into AI infrastructure. Bitfarms also announced a CFO transition and moved its headquarters to the U.S. Analyst targets remain mixed amid ongoing losses.
30 October 2025
···
TeraWulf (WULF) Stock Skyrockets 100% on Google-Backed AI Bet – Clean-Energy Bitcoin Miner Takes Off

TeraWulf (WULF) Stock Skyrockets 100% on Google-Backed AI Bet – Clean-Energy Bitcoin Miner Takes Off

TeraWulf shares surged 17% on Oct. 28, 2025, after announcing a $9.5 billion, 25-year joint venture with Fluidstack and Google to build a 168 MW AI compute campus in Texas. The stock pulled back 9% the next day, closing near $14.50. Year-to-date, WULF is up about 117%. Q3 revenue was pre-announced at $42 million, up 84% year-over-year, with full results due Nov. 10.
30 October 2025
···
Sprouts Farmers Market Stock Plunges 25% on Mixed Q3 Earnings – Analysts Scramble

Sprouts Farmers Market Stock Plunges 25% on Mixed Q3 Earnings – Analysts Scramble

Sprouts Farmers Market shares plunged 25% to near $82 on Oct. 30 after Q3 revenue missed estimates and management cut its Q4 sales outlook. Net sales rose 13% to $2.20 billion and EPS beat forecasts, but Q4 comparable-store growth was guided to just 0–2%. UBS and BMO lowered price targets, citing slowing momentum. The stock’s technical indicators showed severe oversold conditions.
30 October 2025
··
Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Baxter shares fell about 16% to $19 on Oct. 30 after cutting its 2025 outlook and missing Q3 sales forecasts. Q3 revenue rose 5% to $2.84 billion, but sales missed estimates; adjusted EPS of $0.69 beat expectations. The company halted Novum IQ infusion pump shipments after two patient deaths and reported hurricane-related supply disruptions. Andrew Hider became CEO in July.
30 October 2025
·
Guardant Health (GH) Stock Rockets on Earnings Beat and New Cancer-Screening Wins

Guardant Health (GH) Stock Rockets on Earnings Beat and New Cancer-Screening Wins

Guardant Health shares soared nearly 30% to around $94 on Oct. 30, 2025, after Q3 revenue jumped 39% to $265.2 million, beating estimates. The company raised its 2025 revenue outlook to $965–970 million. New partnerships are expanding access to its Shield colorectal cancer test nationwide. Guardant360 received additional FDA approvals and a formal review submission.
30 October 2025
··
CVU Stock Skyrockets 70% on Missile Contract Win – CPI Aerostructures Surges as Analysts Weigh In

CVU Stock Skyrockets 70% on Missile Contract Win – CPI Aerostructures Surges as Analysts Weigh In

CPI Aerostructures shares surged up to 75% intraday on Oct. 30 after announcing a major missile wing contract with Raytheon. The stock traded around $3.50–$3.70 by late morning, reversing from 52-week lows earlier in the week. The new order expands CPI’s presence in missile systems, with deliveries starting in 2026. Financial terms were not disclosed.
30 October 2025
···
Medical Properties Trust Defies Skeptics: Q3 Beat and Buyback Ignite 6%‑Yield REIT Rally

Medical Properties Trust Defies Skeptics: Q3 Beat and Buyback Ignite 6%‑Yield REIT Rally

Shares of Medical Properties Trust closed near $5.00 on Oct. 30, 2025, up 3–4% after Q3 earnings beat expectations, valuing the company at $3 billion. Management authorized a $150 million share buyback and reported improved rent collections. The REIT pays a quarterly dividend of $0.08 per share after recent cuts. Short interest remains high at 37% of float, while institutional ownership stands at 58%.
30 October 2025
··
Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround?

Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround?

Harvard Bioscience shares fell to $0.40 in October 2025, down 84% year-over-year, after hitting a 52-week low of $0.28. Nasdaq granted a 180-day extension to regain $1 compliance, and the company is considering a reverse split. Q2 revenue dropped 12% to $20.5 million, but cash flow improved. Debt refinancing is required by December 2025, and John Duke became CEO in July after Jim Green’s retirement.
30 October 2025
··
Plug Power’s 170% Hydrogen Rally Cools – Can PLUG Stock Reignite?

Plug Power’s 170% Hydrogen Rally Cools – Can PLUG Stock Reignite?

Plug Power shares soared about 170% from late summer lows to a $4.58 peak in early October, then dropped to around $2.8–$2.9 by Oct. 30. The company signed a 2 GW electrolyzer deal in Uzbekistan, raised $370 million, and secured major credit lines. Founder CEO Andy Marsh will step down in 2026. Analysts remain split, with targets ranging from $1 to $4.50.
30 October 2025
······
Intel (INTC) Stock Soars 90% to 18-Month High on AI Boom, $15B Lifeline – Will the Rally Last?

Intel (INTC) Stock Soars 90% to 18-Month High on AI Boom, $15B Lifeline – Will the Rally Last?

Intel stock has surged 85–90% year-to-date, hitting an 18-month high near $42 after a surprise Q3 return to profit and $13.7 billion in revenue. The U.S. government, Nvidia, and SoftBank invested $15 billion in 2025, with Washington taking a 10% stake. New CEO Lip-Bu Tan is steering Intel toward AI and advanced manufacturing. Analysts warn the stock’s valuation, now ~70× forward earnings, far exceeds peers.
30 October 2025
···
Ambev’s Profit Soars 36% in Q3 – Buyback Announced as ABEV Stock Eyes Rally

Ambev’s Profit Soars 36% in Q3 – Buyback Announced as ABEV Stock Eyes Rally

Ambev S.A. reported Q3 net income of 4.86 billion reais, up 36% year-on-year and well above analyst forecasts. Beer volumes fell 5.9%, but higher prices kept revenue flat; EBITDA was R$7.06 billion, beating estimates. The board approved a buyback of up to 208 million shares. Shares traded around $2.25 after results, with analysts split on outlook amid sector headwinds.
30 October 2025
··
FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

FMC Corp shares plunged 42% to $16, their lowest since 2016, after the company posted a $569 million quarterly loss and slashed its dividend by 80%. Revenue fell 49% year-over-year, hit by a $510 million write-down tied to its India business. The company cut its 2024 outlook and announced President Ronaldo Pereira will step down December 15. Analysts downgraded the stock and trimmed price targets.
30 October 2025
·
Conduent’s Ticket Machine Revolution Debuts in Italy Amid Data Breach Fallout and Market Buzz

Conduent’s Ticket Machine Revolution Debuts in Italy Amid Data Breach Fallout and Market Buzz

Conduent launched its DOT1 ticket vending machine with SETA S.p.A. in Italy, offering contactless payments and real-time transit updates. The rollout comes as Conduent faces fallout from a data breach that exposed personal data of at least 4.5 million people in the U.S. The company spent $25 million on breach response and is under investigation. Conduent shares trade near $2.50, down 30% over the past year.
30 October 2025
···
Nvidia’s Record $5 Trillion Surge: AI Mega-Deals Propel NVDA Stock – Is $300 Next?

Nvidia’s Record $5 Trillion Surge: AI Mega-Deals Propel NVDA Stock – Is $300 Next?

Nvidia’s market value topped $5 trillion this week as shares hit $207, following major AI chip deals and new supercomputer plans. Revenue jumped 56% last quarter to $46.7 billion, with the company forecasting 54% growth next quarter. Rival chipmakers AMD and Qualcomm also surged on new AI partnerships, but analysts say Nvidia still dominates supply. Wall Street remains bullish, though some warn the stock is “priced for perfection.”
30 October 2025
··
Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb reported Q3 adjusted EPS of $1.63 on $12.2 billion revenue, beating estimates, and raised its 2025 outlook. Shares rebounded 3–4% after hitting a 52-week low, with dividend yield now near 5.5%. New drugs like Opdivo and Eliquis outperformed, offsetting a sharp Revlimid decline. The company acquired Orbital Therapeutics and launched schizophrenia drug Cobenfy, posting $62 million in early sales.
30 October 2025
··
Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

Altria reported Q3 net revenue down 3% to $6.07 billion and adjusted EPS of $1.45, matching estimates. Shares fell nearly 4% pre-market, trading about 10% below recent highs. The company doubled its buyback program to $2 billion and raised its 2025 earnings outlook floor. Cigarette and oral tobacco sales declined, while NJOY e-cigarette sales remain halted due to a patent dispute.
30 October 2025
···
1 … 62 63 64 65 66 … 148

Stock Market Today

  • JPMorgan Chase Stock Valuation After 25% Annual Gain
    June 16, 2026, 10:10 PM EDT. JPMorgan Chase (JPM) stock closed at $331.14, marking a 25.3% gain over one year. Despite strong returns, its valuation is attracting scrutiny. Simply Wall St rates JPMorgan at 2/6 on valuation metrics. An Excess Returns model estimates an intrinsic value of $435.81 per share, suggesting the stock is 24% undervalued. This model compares JPMorgan's return on equity (16.96%) against the cost of equity, highlighting shareholder profit potential. However, ongoing concerns about interest rates, credit conditions, and capital requirements keep investors cautious. JPMorgan's price-to-earnings (P/E) ratio remains a key metric for assessing whether current prices fairly reflect earnings. Overall, JPMorgan Chase's stock offers potential value but demands close investor attention amid market factors.

Latest articles

Dow Closes at Record in After-Hours as S&P 500, Nasdaq Dip on Tech Slide

Dow Closes at Record in After-Hours as S&P 500, Nasdaq Dip on Tech Slide

17 June 2026
Dow hits second straight record close at 51,999.67 while S&P 500 and Nasdaq drop as tech stocks slide; Philadelphia semiconductor index plunges 5.7% and after-hours trading sees only slight gains for major index-tracking funds, as investors brace for Wednesday’s Fed decision and monitor inflation risks amid falling oil prices and a possible U.S.-Iran deal.
GD Culture shares drop on heavy trading and ongoing buyout uncertainty

GD Culture shares drop on heavy trading and ongoing buyout uncertainty

17 June 2026
GD Culture Group plunged 73.3% to $0.028 after heavy trading, putting fresh pressure on its unresolved, non-binding $10.75-per-share buyout proposal; risks include deal uncertainty, a $300 million share-sale program, and bitcoin-driven balance sheet swings, with no new company updates released Tuesday.
Go toTop